Newsfeeds - Spark Newswire

1 minute read

Avinger Q2 EPS $(0.04), Inline, Sales $2.80M Beat $2.72M Estimate

Today, 5:05 PM

Avinger (NASDAQ:AVGR) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 77.78 percent increase over losses of $(0.18) per share from the same period last year. The

AVGR

10 minute read

Earnings Scheduled For August 10, 2021

By Benzinga Insights

Today, 5:05 PM

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.

ABST

2 minute read

Earnings

Earnings Outlook For Avinger

By Benzinga Insights

Today, 5:05 PM

Avinger (NASDAQ:AVGR) releases its next round of earnings this Tuesday, August 10. Here is Benzinga's essential guide to Avinger's Q2 earnings report.

AVGR

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 5:05 PM

Gainers

ADXS

1 minute read

Avinger Files US Application For New Pantheris In-Stent Restenosis Indication

By Vandana Singh

Today, 5:05 PM

Avinger Inc (NASDAQ:AVGR) has submitted a 510(k) application to the FDA for a new Pantheris clinical indication for the treatment of…

AVGR

3 minute read

News

Avinger Announces 510(k) Filing For New Pantheris In-Stent Restenosis Indication

By Benzinga Newsdesk

Today, 5:05 PM

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today

AVGR